当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 现金流量表

共同药业

(300966)

  

流通市值:17.67亿  总市值:26.61亿
流通股本:7658.01万   总股本:1.15亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金223,856,400.3384,433,474.74509,412,319.88371,928,026.42
  收到的税费返还9,710,971.154,141,895.3839,222,478.8730,885,953.99
  收到其他与经营活动有关的现金13,849,544.2811,820,739.0939,052,082.29,355,868.64
  经营活动现金流入小计247,416,915.76100,396,109.21587,686,880.95412,169,849.05
  购买商品、接受劳务支付的现金148,540,602.7862,915,804.23413,509,131.53291,918,645.29
  支付给职工以及为职工支付的现金47,097,853.823,798,163.9486,527,519.0764,452,964.7
  支付的各项税费7,545,971.931,425,368.616,139,366.2116,621,189.5
  支付其他与经营活动有关的现金21,756,627.4412,154,898.3340,474,473.8145,343,057.92
  经营活动现金流出小计224,941,055.95100,294,235.11546,650,490.62418,335,857.41
  经营活动产生的现金流量净额22,475,859.81101,874.141,036,390.33-6,166,008.36
二、投资活动产生的现金流量:
  收回投资收到的现金-0--
  取得投资收益收到的现金-0--
  处置固定资产、无形资产和其他长期资产收回的现金净额26,2372,832183,709133,709
  处置子公司及其他营业单位收到的现金净额-0--
  收到的其他与投资活动有关的现金-0--
  投资活动现金流入小计26,2372,832183,709133,709
  购建固定资产、无形资产和其他长期资产支付的现金35,471,999.0926,054,569.82166,326,364.17141,243,927.94
  投资支付的现金-0--
  取得子公司及其他营业单位支付的现金-0--
  支付其他与投资活动有关的现金-0--
  投资活动现金流出小计35,471,999.0926,054,569.82166,326,364.17141,243,927.94
  投资活动产生的现金流量净额-35,445,762.09-26,051,737.82-166,142,655.17-141,110,218.94
三、筹资活动产生的现金流量:
  吸收投资收到的现金-0--
  取得借款收到的现金171,000,000110,000,000468,380,787.85364,787,491.18
  收到其他与筹资活动有关的现金3,339,373.230-49,013,137.66
  筹资活动现金流入小计174,339,373.23110,000,000468,380,787.85413,800,628.84
  偿还债务支付的现金146,990,00079,020,000326,064,928.71217,740,000
  分配股利、利润或偿付利息支付的现金12,001,787.955,302,044.2329,831,693.8615,753,048.6
  支付其他与筹资活动有关的现金15,079,770.5313,969,983.3322,298,515.7751,734,496.28
  筹资活动现金流出小计174,071,558.4898,292,027.56378,195,138.34285,227,544.88
  筹资活动产生的现金流量净额267,814.7511,707,972.4490,185,649.51128,573,083.96
四、汇率变动对现金及现金等价物的影响-230,900.892.94-64,040.56-43,987.36
五、现金及现金等价物净增加额-12,932,988.42-14,241,888.34-34,984,655.89-18,747,130.7
  加:期初现金及现金等价物余额65,137,377.1365,137,377.13100,122,033.02100,122,033.02
  期末现金及现金等价物余额52,204,388.7150,895,488.7965,137,377.1381,374,902.32
补充资料:
  净利润-38,353,335.12--81,726,282.34-
  资产减值准备-809,085.54-16,487,980.87-
  固定资产和投资性房地产折旧68,763,649.66-114,319,810.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧68,763,649.66-114,319,810.89-
  无形资产摊销731,190.49-1,037,899.2-
  长期待摊费用摊销1,680,886.38-3,327,673.59-
  处置固定资产、无形资产和其他长期资产的损失131,259.9-1,437,181.19-
  固定资产报废损失--3,789,921.83-
  公允价值变动损失---0.13-
  财务费用25,946,122.68-47,639,353.36-
  投资损失3,510,820.02-291,446.56-
  递延所得税-4,965,343.69--24,508,060.29-
  其中:递延所得税资产减少-4,948,318.13--25,479,914.25-
    递延所得税负债增加-17,025.56-971,853.96-
  存货的减少-24,548,230.28--99,524,102.77-
  经营性应收项目的减少-56,677,041.51-25,467,407.79-
  经营性应付项目的增加46,020,255.89-34,603,579.58-
  其他1,016,179.12--1,664,120.32-
  现金的期末余额52,204,388.71-65,137,377.13-
  减:现金的期初余额65,137,377.13-100,122,033.02-
  现金及现金等价物的净增加额-12,932,988.42--34,984,655.89-
公告日期2026-08-262026-04-292026-04-292025-10-28
审计意见(境内)标准无保留意见
TOP↑